Skip to main content
. 2025 Aug 15;16:181. doi: 10.1186/s13244-025-02058-7

Fig. 1.

Fig. 1

Examples of the molecular, genetic, pathologic, clinical, and serum markers in proliferative and non-proliferative HCC. AFP, alpha-fetoprotein; AKT, protein kinase B; ALD, alcohol-associated liver disease; AXIN1, axis inhibitor 1; CDH1, cadherin 1; CDKN2A, cyclin-dependent kinase inhibitor 2A; CTNNB1, catenin beta-1; MASLD, metabolic dysfunction-associated steatotic liver disease; PIK3CA, phosphoinositide-3-kinase-catalytic-alpha; TGF-β, transforming growth factor-β; TP53, tumor protein p53